Hematology

Dr. Suzanne Lentzsch is a Professor of Clinical Medicine and the Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and…

Thomas G. DeLoughery, MD, MACP, FAWM

Heather J. Landau, MD

Eli Muchtar, MD

Larry Anderson, MD, PhD

Larry Anderson is Associate Professor in University of Texas (UT) Southwestern Medical Center's Department of Internal Medicine, Division of Hematology/Oncology…

Saad Z. Usmani, MD

Saad Zafar Usmani joined Levine Cancer Institute as the Director of Plasma Cell Disorder Program and the Director of Clinical Research in Hematologic Malignancies…

Michael Alan Rosenzweig, MD, MS

Michael Alan Rosenzweig is an Associate Professor of Hematology & Hematopoietic Cell Transplantation at City of Hope Medical Center. Dr. Rosenzweig received his…

Sascha Tuchman, MD, MHS

Sascha Tuchman is Associate Professor and Director of the University of North Carolina Multiple Myeloma and Amyloidosis Program. He earned his medical degree from…

Carol Ann Huff, MD

Carol Ann Huff is an Associate Professor of Oncology and Medicine at the Johns Hopkins University School of Medicine and Medical Director for the Johns Hopkins…

Subscribe to

Newsletter

Expert and Community Perspectives on Attruby®

In this special session, Dr. Barry Trachtenberg and members of the ATTR amyloidosis community came together to share medical insights and lived experiences related to Attruby™ (acoramidis). This expert-led discussion explores the clinical data, the patient perspective, and what lies ahead for those considering or currently taking Attruby.